跳至主要内容
临床试验/jRCTs041200112
jRCTs041200112已完成不适用

Preventive effect of ramelteon on delirium in ICU

未提供0 个研究点目标入组 220 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
220
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Prevention Purpose
盲法
Double Blind

入排标准

年龄范围
40age old over 至 No limit(—)
性别
All

入选标准

  • ICU patients 18 years old or more, expected to stay in ICU for over 48 hours.
  • Patients registered within 48hours of ICU admission and administrated first medication on the registration day.

排除标准

  • Patients under 18 years old.
  • Allergy to ramelteon.
  • Patients with severe liver injury (T-Bil >= 10 mg/dL, or ALT >= 750 IU/L).
  • Patients receiving fluvoxamine maleate.
  • Patients already receiving ramelteon therapy before admission.
  • Patients expected to leave ICU within 48 hours of admission.
  • Patients expected to die within 48 hours of admission or be excluded from active treatment.
  • Pregnant or lactating women.
  • Patients expected to be difficult to evaluate delirium by CAM-ICU due to neurological problems such as post-cardiac arreest, head trauma, stroke, or other illness.
  • Absence of written informed consent.

结局指标

主要结局

-

Occurrence of ICU-delirium

次要结局

  • Ventilator free days(Day 1 to day 28)

研究者

发起方
未提供

相似试验

Preventive effect of ramelteon on delirium in ICU | 临床试验